FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved Chartwell RX, LLC's supplemental application for ketorolac tromethamine (ANDA210616), confirming changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)